Phibro Animal Health Stock
Phibro Animal Health Corporation
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- CEO
- Daniel Bendheim
- Employees
- 2,605
- Market cap
- $1.6 B
- IPO
- 11/04/2014
- Web
- www.pahc.com
Phibro Animal Health Corporation is a healthcare company headquartered in Teaneck, US, specializing in the research, production, and supply of animal health and mineral nutrition solutions. The company is listed on the NASDAQ and went public on April 11, 2014. Its operations are organized into three main business…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Phibro Animal Health stock: price history
1D
+2.2%
1W
+1.4%
1M
+10.0%
6M
-32.0%
YTD
+3.9%
1Y
+0.6%
2Y
+56.3%
5Y
+78.1%
10Y
+52.0%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~97% stronger price swings than usual
Ask the agents about Phibro Animal Health
Analyst assessment of Phibro Animal Health
PRICE TARGET LOW
US$17.00
CONSENSUS
US$28.00
MEDIAN
US$18.00
PRICE TARGET HIGH
US$49.00
0
STRONG BUY
6
BUY
4
HOLD
4
SELL
0
STRONG SELL
14
TOTAL · Buy
As of: 14/05/2026
Phibro Animal Health stock metrics
P/E
15.78
P/B
4.09
EV/EBITDA
9.74
RETURN ON EQUITY
5.6%
NET MARGIN
5.5%
DEBT/EQUITY
2.05
DIVIDEND YIELD
1.2%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.3%
FLOAT SHARES
40,301,191
AVG. DAILY VOLUME (30D)
238,658
Insider transactions (SEC)
Bendheim Daniel M
Rodriguez Patrick
David Glenn
Miller Larry Lee
BENDHEIM Jonathan
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about Phibro Animal Health stock
What does Phibro Animal Health do?
Phibro Animal Health Corporation is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in United States.
The CEO is Daniel Bendheim, the company employs around 2,605 people.
The IPO was on 11/04/2014; the stock trades on NASDAQ under the ticker PAHC.
What do analysts say about Phibro Animal Health stock?
14 analysts rate the stock, the consensus is Buy (as of 14/05/2026).
The average price target is US$28.00, ranging from US$17.00 to US$49.00, with a median of US$18.00.
This is an external assessment, not a statement by Market Jury.
When does Phibro Animal Health report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 97% stronger than usual.
Does Phibro Animal Health pay a dividend?
Yes. The last dividend was US$0.12 per share, ex-date 02/09/2026, paid on 23/09/2026.
The dividend yield is 1.2% (as of 30/06/2026).
Which stocks are comparable to Phibro Animal Health?
Comparable stocks include Zoetis, Viatris, Lantheus Holdings, Amneal Pharmaceuticals, Indivior Pharmaceuticals, Eton Pharmaceuticals, Pacira BioSciences and Amphastar Pharmaceuticals.
How can I get Phibro Animal Health stock analyzed?
Clicking "Analyze stock" lets five strategies assess Phibro Animal Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.